Acu-Flow Limited, trading as Nebu~Flow, is an active limited company registered in England and Wales with registration number 16292464. The company was created on March 4, 2025. It operates from an address at Churchill House, 120 Bunns Lane, London, NW7 2AS, managed through Archer Associates. Nebu~Flow’s primary industry, as defined by its SIC code (43290), is listed as ‘None’. The company’s website indicates it specializes in nebuliser development, focusing on “life changing treatments delivery.” The company size is currently unknown, though it is a limited company. Financial records show no available accounts, with no charges registered and the company is not insolvent. Visa information indicates a Skilled Worker status with a rating of ‘Worker (A)’. The company’s website suggests a commitment to innovation within the medical device sector, specifically targeting advancements in nebuliser technology. There is no evidence of international presence or current hiring activity. The company's core business revolves around the development of next-generation nebulisers, implying a relatively small operation, likely focused on research and development and potentially limited manufacturing, given the lack of publicly available financial data and the “Unknown” company size.

Acu-Flow Limited, trading as Nebu~Flow, is an active limited company registered in England and Wales with registration number 16292464. The company was created on March 4, 2025. It operates from an address at Churchill House, 120 Bunns Lane, London, NW7 2AS, managed through Archer Associates. Nebu~Flow’s primary industry, as defined by its SIC code (43290), is listed as ‘None’. The company’s website indicates it specializes in nebuliser development, focusing on “life changing treatments delivery.” The company size is currently unknown, though it is a limited company. Financial records show no available accounts, with no charges registered and the company is not insolvent. Visa information indicates a Skilled Worker status with a rating of ‘Worker (A)’. The company’s website suggests a commitment to innovation within the medical device sector, specifically targeting advancements in nebuliser technology. There is no evidence of international presence or current hiring activity. The company's core business revolves around the development of next-generation nebulisers, implying a relatively small operation, likely focused on research and development and potentially limited manufacturing, given the lack of publicly available financial data and the “Unknown” company size.